ENDOBON? XENOGRAFT GRANULES 1.0ML ROX10

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2018-04-26 for ENDOBON? XENOGRAFT GRANULES 1.0ML ROX10 manufactured by Biomet France S.a.r.l..

Event Text Entries

[106604651] (b)(4). Report source, foreign - event occurred in (b)(6). The product has not been returned to the manufacturer. Therefore, the product evaluation could not be performed. The dhr has been reviewed and no discrepancies were found. The root cause of the event could not be determined. If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
Patient Sequence No: 1, Text Type: N, H10


[106604652] A non integration of the bone materials copios cancellous particulate xenograft 0. 25-1mm, 1,0 cc and endobon xenograft granules 1. 0 ml has been reported by the doctor petrement. The granules did not transform into bone. The patient had infection, inflammation, healing delay and pain. In anticipation of the placement of 3 implants 6 months later, the doctor performed a lateral sinus lift on (b)(6) 2017: the doctor used one copios cancellous particulate xenograft 0. 25-1mm, 1,0 cc, and used in addition to the filling two endobon xenograft granules 1. 0 ml. On (b)(6) 2018, the doctor saw the patient in consultation to proceed with the placement of 3 implants in the dental location 24, 25 and 26 (universal system of dental location). The doctor diagnosed that the site was not healthy. He found that the particulates were not processed, and a suspicious and "elastic" form was present. The doctor nevertheless placed the implants. The doctor proceeded to the removal of the material and the trimming on (b)(6) 2018 as the implants were not osseointegrated, the bone height was insufficient because the filling was not transformed. Additionally the patient had a slight pain, dr. Petrement found a beginning of inflammation of the gingiva and a presence of pus in the sinus.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006946279-2018-00147
MDR Report Key7464295
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2018-04-26
Date of Report2018-04-26
Date of Event2018-03-02
Date Mfgr Received2018-03-30
Device Manufacturer Date2017-04-07
Date Added to Maude2018-04-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS H BATAILLE
Manufacturer StreetPLATEAU DE LAUTAGNE BP75
Manufacturer CityVALENCE CEDEX 26903
Manufacturer CountryFR
Manufacturer Postal26903
Manufacturer Phone0334757594
Manufacturer G1BIOMET FRANCE S.A.R.L
Manufacturer StreetPLATEAU DE LAUTAGNE BP75
Manufacturer CityVALENCE CEDEX 26903
Manufacturer CountryFR
Manufacturer Postal Code26903
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameENDOBON? XENOGRAFT GRANULES 1.0ML
Generic NameBONE GRAFTING MATERIAL, SYNTHETIC
Product CodeLYC
Date Received2018-04-26
Catalog NumberROX10
Lot NumberW0173100
ID Number(01) 0 3599870 09126 5
Device Expiration Date2018-09-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMET FRANCE S.A.R.L.
Manufacturer AddressPLATEAU DE LAUTAGNE BP75 VALENCE CEDEX 26903 FR 26903


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-04-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.